Patents Assigned to CUPIONE CO., LTD.
  • Composition for inhibiting immune cell proliferation comprising sialyllactose or derivative thereof and method thereof
    Patent number: 11672815
    Abstract: Provided are a composition for inhibiting immune cell proliferation, including sialyllactose or a derivative thereof as an active ingredient, and a method of inhibiting immune cell proliferation, wherein the composition and the method may decrease expression of chemokines, decrease expression of pro-inflammatory cytokines, decrease production of inflammatory mediators, decrease expression of COX2, and decrease production of PEG2, and therefore, may be useful for the prevention or treatment of atopic dermatitis or arthritis.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: June 13, 2023
    Assignee: CUPIONE CO., LTD.
    Inventors: Siyoung Yang, Jimin Jeon, Li-Jung Kang, Chanmi Cho
  • COMPOSITION FOR INHIBITING IMMUNE CELL PROLIFERATION COMPRISING SIALYLLACTOSE OR DERIVATIVE THEREOF AND METHOD THEREOF
    Publication number: 20220362270
    Abstract: Provided are a composition for inhibiting immune cell proliferation, including sialyllactose or a derivative thereof as an active ingredient, and a method of inhibiting immune cell proliferation, wherein the composition and the method may decrease expression of chemokines, decrease expression of pro-inflammatory cytokines, decrease production of inflammatory mediators, decrease expression of COX2, and decrease production of PEG2, and therefore, may be useful for the prevention or treatment of atopic dermatitis or arthritis.
    Type: Application
    Filed: December 29, 2021
    Publication date: November 17, 2022
    Applicant: CUPIONE CO., LTD.
    Inventors: Siyoung YANG, Jimin JEON, Li-Jung KANG, Chanmi CHO
  • Composition for inhibiting immune cell proliferation comprising sialyllactose or derivative thereof and method thereof
    Patent number: 11291676
    Abstract: Provided are a composition for inhibiting immune cell proliferation, including sialyllactose or a derivative thereof as an active ingredient, and a method of inhibiting immune cell proliferation, wherein the composition and the method may decrease expression of chemokines, decrease expression of pro-inflammatory cytokines, decrease production of inflammatory mediators, decrease expression of COX2, and decrease production of PEG2, and therefore, may be useful for the prevention or treatment of atopic dermatitis or arthritis.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: April 5, 2022
    Assignee: CUPIONE CO., LTD.
    Inventors: Siyoung Yang, Jimin Jeon, Li-Jung Kang, Chanmi Cho
  • COMPOSITION FOR INHIBITING IMMUNE CELL PROLIFERATION COMPRISING SIALYLLACTOSE OR DERIVATIVE THEREOF AND METHOD THEREOF
    Publication number: 20210236525
    Abstract: Provided are a composition for inhibiting immune cell proliferation, including sialyllactose or a derivative thereof as an active ingredient, and a method of inhibiting immune cell proliferation, wherein the composition and the method may decrease expression of chemokines, decrease expression of pro-inflammatory cytokines, decrease production of inflammatory mediators, decrease expression of COX2, and decrease production of PEG2, and therefore, may be useful for the prevention or treatment of atopic dermatitis or arthritis.
    Type: Application
    Filed: February 2, 2021
    Publication date: August 5, 2021
    Applicant: CUPIONE CO., LTD.
    Inventors: Siyoung YANG, Jimin JEON, Li-Jung KANG, Chanmi CHO